Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mediwound Ltd Ord Sh (NQ: MDWD ) 18.55 -0.22 (-1.17%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 76,637 Open 18.67 Bid (Size) 16.34 (2) Ask (Size) 18.50 (7) Prev. Close 18.77 Today's Range 18.11 - 18.98 52wk Range 7.100 - 24.00 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns August 15, 2024 Approval Helps Solidify NexoBrid’s Position in the U.S. as a Safe and Effective Non-Surgical Burn Treatment for All Ages From MediWound Ltd. Via GlobeNewswire MDWD Stock Earnings: MediWound Misses EPS, Beats Revenue for Q2 2024 August 14, 2024 MDWD stock results show that MediWound missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. Via InvestorPlace Performance YTD +64.89% +64.89% 1 Month -4.23% -4.23% 3 Month +4.27% +4.27% 6 Month +32.50% +32.50% 1 Year +110.08% +110.08% More News Read More MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update August 14, 2024 From MediWound Ltd. Via GlobeNewswire MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT) August 05, 2024 From MediWound Ltd. Via GlobeNewswire Preview: MediWound's Earnings March 20, 2024 Via Benzinga MediWound to Report Second Quarter 2024 Financial Results August 02, 2024 From MediWound Ltd. Via GlobeNewswire MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers July 29, 2024 From MediWound Ltd. Via GlobeNewswire MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program July 16, 2024 From MediWound Ltd. Via GlobeNewswire MediWound Announces $25 Million Strategic Private Placement Financing July 15, 2024 From MediWound Ltd. Via GlobeNewswire Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session July 05, 2024 Via Benzinga US Stocks Mixed; Jobs Figures Top Estimates For June July 05, 2024 Via Benzinga Why Sharps Technology Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket July 05, 2024 Via Benzinga MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q1 2024 May 29, 2024 Via InvestorPlace MediWound Reports First Quarter 2024 Financial Results and Provides Company Update May 29, 2024 From MediWound Ltd. Via GlobeNewswire MediWound to Report First Quarter 2024 Financial Results May 22, 2024 From MediWound Ltd. Via GlobeNewswire MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences April 25, 2024 From MediWound Ltd. Via GlobeNewswire MediWound Ltd. (NASDAQ: MDWD) Sets New 52-Week High in Wednesday Session April 17, 2024 Via Investor Brand Network MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q4 2023 March 21, 2024 Via InvestorPlace MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update March 21, 2024 From MediWound Ltd. Via GlobeNewswire MediWound to Report Fourth Quarter and Full Year 2023 Financial Results March 14, 2024 From MediWound Ltd. Via GlobeNewswire Earnings Scheduled For March 21, 2024 March 21, 2024 Via Benzinga MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study February 12, 2024 From MediWound Ltd. Via GlobeNewswire MediWound to Participate in Two Upcoming Investor Conferences February 05, 2024 From MediWound Ltd. Via GlobeNewswire MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns January 09, 2024 From MediWound Ltd. Via GlobeNewswire Innovative Burn Care: MediWound Bags Additional DoD Grant For NexoBrid Development December 28, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
